Addressing attention-deficit/hyperactivity disorder in later adulthood

Clinical Geriatrics

Volumn 16, Issue 11, 2008, Pages 33-39

  Wetzel, Martin W ^a   Burke, William J ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DEXAMPHETAMINE; DULOXETINE; METHYLPHENIDATE; MODAFINIL;

ADULT; ADULTHOOD; AGED; ANHEDONIA; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; DEPRESSION; DISORIENTATION; DISTRACTIBILITY; DIZZINESS; DRUG DOSE TITRATION; DRUG SUBSTITUTION; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; MALE; MENTAL HEALTH; READING; TIME MANAGEMENT;

EID: 57749099044     PISSN: 10951598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Biederman J, Faraone SV. The effects of attention-deficit/hyperactivity disorder on employment and household income. Med Gen Med 2006;8:12.
2. Wender PH, Wolf LE, Wasserstein J. Adults with ADHD: An overview. Ann N Y Acad Sci 2001;931:1-16.
3. Guze SB. Nature of psychiatric illness: Why psychiatry is a branch of medicine. Compr Psychiatry 1978;19:295-307.
4. Seidman LJ. Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev 2006;26:466-485. Published Online: February 13, 2006.
5. Spencer T, Biederman J, Wilens T. Stimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004;27:361-372.
6. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychol Med 2006;36:159-165.
7. Biederman J, Petty CR, Fried R, et al. Stability of executive function deficits into young adult years: A prospective longitudinal follow-up study of grown up males with ADHD. Acta Psychiatr Scand 2007;116:129-136.
8. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-723.
9. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190:402-409.
10. American Psychiatric Association. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision. Washington, DC: American Psychiatric Association; 2000:xi.
11. Faraone SV, Biederman J, Spencer T, et al. Diagnosing adult attention deficit hyperactivity disorder: Are late onset and subthreshold diagnoses valid? Am J Psychiatry 2006;163:1720-1729, 1859.
12. Adult ADHD Self-Report Scale (ASRS). National Comorbidity Survey Website. www.hcp.med.harvard.edu/ncs/asrs.php. Accessed July 2, 2008.
13. Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS). Psychol Med 2005;35(2):245-256.
14. Weiss M, Hechtman L; The Adult ADHD Research Group. A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry 2006;67:611-619.
15. Levinoff EJ, Saumier D, Chertkow H. Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment. Brain Cogn 2005;57:127-130.
16. Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 2007;81:235-241. Published Online December 27, 2006.
17. Jagust W, Gitcho A, Sun F, et al. brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol 2006;59:673-681.
18. Swick D, Senkfor AJ, Van Petten C. Source memory retrieval is affected by aging and prefrontal lesions: Behavioral and ERP evidence. Brain Res 2006;1107:161-176. Published Online July 7, 2006.
19. Gazzaley A, Cooney JW, Rissman J, D'esposito M. Top-down suppression deficit underlies working memory impairment in normal aging [published correction appears in Nat Neurosci 2005;8(12):1791]. Nat Neurosci 2005;8(10):1298-1300.
20. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: Adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006;45:192-202.
21. Hoza B, Mrug S, Gerdes AC, et al. What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder? J Consult Clin Psychol 2005;73:411-423.
22. Biederman J, Faraone SV, Spencer TJ, et al. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry 2006;67:524-540.
23. ADHD: Applying practice guidelines to improve patient outcome and executive function. J Clin Psychiatry 2006;67:2014-2025.
24. Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother 2005;5:525-539.
25. Safren SA. Cognitive-behavioral approaches to ADHD treatment in adulthood. J Clin Psychiatry 2006;67 Suppl 8:46-50.
26. Poulton A. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder. Expert Rev Neurother 2006;6:551-561.
27. Wilens TE, Zusman RM, Hammerness PG, et al. An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/ hyperactivity disorder and treated primary essential hypertension. J Clin Psychiatry 2006;67:696-702.
28. Jacobs W. Fatal amphetamine-associated cardiotoxicity and its medicolegal implications. Am J Forensic Med Pathol 2006;27:156-160.
29. FDA directs ADHD drug manufacturers to notify patients about cardiovascular adverse events and psychiatric adverse events. U.S. Food and Drug Administration Website. www.fda.gov/bbs/topics/NEWS/2007/NEW01568.html. Accessed July 2, 2008.
30. U.S. Food and Drug Administration: AHRQ and FDA to collaborate in largest study ever of possible heart risks with ADHD medications. www.fda.gov/bbs/ topics/NEWS/2007/NEW01700.html. Accessed July 2, 2008.
31. Distelhorst JS, Hughes GM. Open-angle glaucoma. Am Fam Physician 2003;67:1937-1944.
32. Masand PS, Tesar GE. Use of stimulants in the medically ill. Psychiatr Clin North Am 1996;19:515-547.
33. Roccaforte WH, Burke WJ. Use of psychostimulants for the elderly. Hosp Community Psychiatry 1990;41:1330-1333.
34. Able SL, Johnston JA, Adler LA, Swindle RW. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med 2007;37:97-107. Published Online August 29, 2006.
35. Weiss MD, Gadow K, Wasdell MB. effectiveness outcomes in attention-deficit/hyperactivity disorder. J Clin Psychiatry 2006;67 Suppl 8:38-45.
36. Barkley RA. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guilford Press; 2006.